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Volume 52, Number 6 Abstracts 1745Conclusions: Despite a constant number of yearly intact AAA repair,
national EVAR utilization increased over the study period. Perioperative
mortality was lower after EVAR but there was no difference in long-term
survival and no regional differences in mortality for either cohort. In
addition, EVAR was performed with a lower hospital cost than OPEN. This
large national study further supports the use of EVAR as the first-line therapy
for intact AAA.
Midwest Northeast South West National
Number of patients OPEN 10,195 6175 13,571 4722 34,663
EVAR 18,433 13,012 28,102 8,823 68,370
%EVAR 64.4% 67.8% 67.4% 65.1% 66.4%
P  .001
30-mortality OPEN 4.9% 4.8% 5.0% 4.6% 4.9%
EVAR 2.6% 1.9% 2.4% 2.5% 1.6%
P  .001 (OPEN vs EVAR)
5-year survival OPEN 74.4% 73.8% 72.7% 74.1% 73.6%
EVAR 75.5% 73.6% 74.1% 75.3% 74.6%
(P  .4 for OPEN vs EVAR, P  .9 for regions)
Randomized Clinical Trial of Open-Cell vs Closed-Cell Stents for
Carotid Stenting: Effects of Stent Design on Cerebral Embolization
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Gregory Modrall, G. Patrick Clagett, University of Texas, SW Medical
Center, Dallas, Tex
Background: The effect of stent design on cerebral embolization has
not been established. The purpose of this trial was to contrast the incidence
of cerebral embolization in high-risk patients undergoing carotid artery
stenting (CAS) with open-cell vs closed-cell stents.
Methods: During an 18-month period, 40 patients were randomized
(1:1) to undergo CASwith open-cell (Acculink, n 20) or closed-cell stents
(Xact, n  20). A single filter device for embolic protection (Accunet filter)
was used. Transcranial Doppler (TCD)-detected microembolic signals
(MES) during CAS and pre- and 24-hour postprocedural diffusion-
weighted magnetic resonance imaging (DW-MRI) were used to determine
cerebral embolization. Univariate and nonparametric analyses were used to
assess associations between stent design and cerebral embolization.
Results: CAS was performed in 16 (41%) symptomatic and 24 (59%)
asymptomatic patients with equal number of open-cell and closed-cell stents
(8/8 and 12/12, respectively). The total and poststenting median MES
counts detected by TCD were 225 (interquartile range [IQR], 191-257)
and 59 (IQR, 43-123) for open-cell stents and 281 (IQR, 134-372) and 74
(IQR, 41-88) for closed-cell stents, respectively (P .4). New acute cerebral
emboli detected with DW-MRI occurred in 47% and 53% of patients
undergoing CAS with open-cell and closed-cell stents, respectively (P .9).
The total and ipsilateral median number of DW-MRI lesions between
groups were not statistically significantly different, ie, 1.5 (IQR, 0-3.75) and
1 (IQR, 0-2) for open-cell stents and 2 (IQR, 0-3) and 1 (IQR, 0-3) for
closed cell-stents, respectively (P  .7). One asymptomatic patient under-
going CAS with an open-cell stent sustained a minor stroke; the 30-day
stroke-death rate in this series was 2.5%.
Conclusions: Cerebral embolization, as detected by TCD and DW-
MRI, occurs with similar frequency after CAS with open-cell and closed-cell
stents. This randomized trial does not support the superiority of any stent
design with respect to cerebral embolization.
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Background: Deep vein thrombosis (DVT) and pulmonary embolism
(PE) are significant sources of postoperative morbidity and mortality and are
currently major quality improvement initiatives. Mechanical and pharmaco-
logical prophylaxis is effective in preventing postoperative thromboembolic
events, thromboprophylaxis is usually discontinued after discharge. We
postulated that patients may still be at risk of venous thromboembolic
disease (VTE) after discharge and and tested this hypothesis in patients
undergoing colorectal resection for cancer, a high-risk population.
Methods: The ACS NSQIP database was queried for patients under-
going colorectal resections for cancer based on the primary procedure CPT
code and operative ICD-9 diagnosis code from 2005 to 2008. The outcome
analyzed was 30-day DVT and/or PE. DVT/PE occurrences were analyzed
by postoperative day, rate relative to hospital length of stay, and by whether
they occurred in-hospital or after initial discharge. Multivariable forward
stepwise regression (P for entry  .05, for exit  .10) was used to identify
independent predictors of DVT.Results: The database contained 21,943 colorectal cancer resections.
DVT/PE (both inpatient and outpatient) rates increased linearly from 0.8%
in patients with length of stay (LOS) less than 1 week to 11.6% in patients
with LOS greater than 3weeks (2 test for linear trend, P .001, Fig 1). The
DVT rate was 1.4% (306/21,943) of which 29% (89/306) were diagnosed
post discharge. The PE rate 0.8% (180/21,943) of which 33% (60/180)
were diagnosed post discharge. Patients were diagnosed with both only 40
times and the combined DVT or PE rate was 2.0% (446/21,943). The ratio
of outpatient to inpatient VTE rate as related to days that elapsed from the
surgical procedure is shown in Figure 2. Independent risk factors for
postdischarge DVT/PE were preoperative steroid use for chronic condition
(n  575, odds ratio 2.90, 95% CI 1.51-5.57, P  .001) and preoperative
systemic inflammatory response syndrome (n  875, odds ratio 2.26, 95%
CI 1.24-4.10, P  .008)
Conclusions:Analysis of theNSQIP database shows increasing rates of
VTE as hospital LOS increases. It was surprising to find that diagnosis of
almost 1/3 of postoperative VTE in this patient population occurs after
discharge. The duration of the prothrombotic stimulus of surgery is not well
defined and patients with malignancy are at high risk of VTE. It is conceiv-
able that thromboprophylaxis after discharge should be considered for these
patients. Additional studies may identify other patient groups in similar risk.
Diastolic Function Predicts Survival After Renal Revascularization
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Baptist Medical Center, Winston-Salem, NC; 2Emory University School of
Medicine, Atlanta, Ga
Background: To define the relationship between left ventricular dia-
stolic function and survival after renal revascularization.
Methods: Seventy-six adult patients (49 women, 27 men; mean age:
63 years  13 years) with preoperative echocardiography who underwent
renal revascularization for atherosclerotic disease were identified. Echocar-
diograms were performed and interpreted according to American Society of
Echocardiography Recommendations for Use of Echocardiography in Clin-
ical Trials. Diastolic function was estimated by measuring the early diastolic
